000071222 001__ 71222
000071222 005__ 20220617151026.0
000071222 0247_ $$2doi$$a10.1186/s42155-018-0008-2
000071222 0248_ $$2sideral$$a106804
000071222 037__ $$aART-2018-106804
000071222 041__ $$aeng
000071222 100__ $$aMayoral Campos, Victoria
000071222 245__ $$aCarotid artery stenting in a single center, single operator, single type of device and 15 years of follow-up
000071222 260__ $$c2018
000071222 5060_ $$aAccess copy available to the general public$$fUnrestricted
000071222 5203_ $$aBackground: Revascularization with carotid stent (CAS) is considered the therapeutic alternative to endarterectomy (CEA). However, its role compared to CEA remains questioned, mainly due of the heterogeneity of long-term results. The objective of this study was to report the efficacy and durability of CAS in terms of stroke prevention in a “real world experience”.
Method: This was a single-center retrospective analysis of 344 patients treated with CAS between January 2001 and December 2015.
The primary outcome of the trial was stroke, myocardial infarction, or death during a periprocedural period or
any stroke event over a 15-year follow-up. The secondary aim was to identify risk factors for 30-day complications, long-term neurological complications, and intra-stent restenosis.
Results: The primary composite end point (any stroke, myocardial infarction, or death during the periprocedural period) was 2.3%. The use of an EPD was protective against major complications.
Long-term follow-up was achieved in 294 patients (85,5%) with a median of 50 months (range 0-155 months). Fifty-six (16,3%) died within this period, most commonly of nonvascular causes (4 patients had stroke-related deaths). During the follow-up period, 8 strokes and 3 TIAs were diagnosed (3.2%).
ISR determined by sequential ultrasound was assessed in 4.4% of the patients and remained asymptomatic in all but 2 patients (0.6%). All patients with restenosis underwent revascularization with balloon angioplasty.
Conclusion: The long-term follow-up results of our study validate CAS as a safe and durable procedure with which to prevent ipsilateral stroke, with an acceptable rate of restenosis, recurrence and mortality.
000071222 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000071222 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000071222 700__ $$0(orcid)0000-0002-0113-5121$$aGuirola Órtiz, José Andrés
000071222 700__ $$aTejero Juste, Carlos
000071222 700__ $$0(orcid)0000-0002-0249-4687$$aGimeno Peribáñez, María José$$uUniversidad de Zaragoza
000071222 700__ $$0(orcid)0000-0002-8880-6580$$aSerrano, Carolina$$uUniversidad de Zaragoza
000071222 700__ $$aPérez Lázaro, Cristina$$uUniversidad de Zaragoza
000071222 700__ $$0(orcid)0000-0002-1204-4356$$ade Blas Giral, Ignacio$$uUniversidad de Zaragoza
000071222 700__ $$0(orcid)0000-0002-5618-7519$$ade Gregorio Ariza, Miguel Ángel$$uUniversidad de Zaragoza
000071222 7102_ $$11010$$2770$$aUniversidad de Zaragoza$$bDpto. Pediatría Radiol.Med.Fís$$cÁrea Radiol. y Medicina Física
000071222 7102_ $$11009$$2773$$aUniversidad de Zaragoza$$bDpto. Patología Animal$$cÁrea Sanidad Animal
000071222 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000071222 7102_ $$11009$$2617$$aUniversidad de Zaragoza$$bDpto. Patología Animal$$cÁrea Medicina y Cirugía Animal
000071222 773__ $$g1, 3 (2018), [8 pp.]$$pCVIR Endovasc.$$tCVIR endovascular$$x2520-8934
000071222 8564_ $$s641757$$uhttps://zaguan.unizar.es/record/71222/files/texto_completo.pdf$$yVersión publicada
000071222 8564_ $$s98054$$uhttps://zaguan.unizar.es/record/71222/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000071222 909CO $$ooai:zaguan.unizar.es:71222$$particulos$$pdriver
000071222 951__ $$a2022-06-17-15:01:48
000071222 980__ $$aARTICLE